CIK 0001807120
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Design Therapeutics, Inc.
Sign in to watch- Ticker
- DSGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823929248
- Phone
- +1 858-293-4900
- Business address
- 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-10 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2024-06-13 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2024-03-25 | Schmid John P. Director | Purchase | +17,809 | $3.74 | $67K | 26,965 |
| 2024-03-22 | Schmid John P. Director | Purchase | +9,156 | $3.62 | $33K | 9,156 |
| 2023-05-31 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-15 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-03-25 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 1 of 1 · 8 trades